Mylan commercially launches Remdesivir under brand name DESREM in India Mylan received license from Gilead for commercialisation of Remdesivir
Mylan to launch COVID-19 remdisivir drug in India for Rs 4,800 Secures regulatory approval for Remdesivir Lyophilsed Powder for injection 100 mg/vial in India Mylan announced that the Drug…
